In a fireside chat with senior analyst Pablo Zuanic on October 23, 2024, Tilray Brands TLRY CEO Irwin Simon shared insights into the company's growth strategies, highlighting profitability, U.S. market entry and the expansion of their cannabis and beverage businesses. Simon also addressed the recent quarterly performance and challenges the company faces in both domestic and international markets.Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox fo ...

LITTLETON, Colo., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Breckenridge Brewery, a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), announced today the release of its seasonal Funslinger Lager, a crisp and easy-drinking beer that’s the perfect companion to kick off winter’s adventures. The Funslinger 12pk and draft is available exclusively in Colorado; Funslinger is also part of Breckenridge Brewery’s variety 15pk available at select retailers across the U.S. Funslinger Lager celebrates local art t ...

I am a market enthusiast and part-time trader. I started writing for Seeking Alpha in 2011, and it has been a tremendous opportunity and learning experience. I have been interested in the markets since elementary school, and hope to pursue a career in the investment management industry. I have been active in the markets for several years, and am primarily focused on long/short equities. I hold a Bachelor of Science Degree from Lehigh University, where I double majored in Finance and Accounting, with a minor ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38594 | --- | --- | |----------------------------------------------------------------------------------------------------------- ...

Tilray Brands, Inc. (NASDAQ:TLRY) Q1 2025 Earnings Conference Call October 10, 2024 8:30 AM ET Company Participants Berrin Noorata - Chief Corporate Affairs and Communications Officer Irwin Simon - Chairman and CEO Carl Merton - CFO Denise Faltischek - Chief Strategy Officer and Head of International Blair MacNeil - President of Tilray Canada Conference Call Participants Kaumil Gajrawala - Jefferies Aaron Grey - Alliance Global Partners Matt Bottomley - Canaccord Genuity Bill Kirk - ROTH MKM Michael Lavery ...

About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, The ...

For the quarter ended August 2024, Tilray Brands, Inc. (TLRY) reported revenue of $200.04 million, up 13.1% over the same period last year. EPS came in at -$0.04, compared to -$0.10 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $219.36 million, representing a surprise of -8.81%. The company delivered an EPS surprise of +20.00%, with the consensus EPS estimate being -$0.05. While investors closely watch year-over-year changes in headline numbers -- revenue and earn ...

Tilray Brands, Inc. (TLRY) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to loss of $0.10 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 20%. A quarter ago, it was expected that this company would post a loss of $0.02 per share when it actually produced a loss of $0.04, delivering a surprise of -100%. Over the last four quarters, the company has surpas ...

Revenue Growth - Q1 net revenue increased 13% year-over-year to $200 million[1][3] - Net revenue grew by 13% to $200,044 from $176,949[19] - Beverage alcohol net revenue surged 132% to $56.0 million in Q1[3] - Beverage alcohol business revenue surged to $55,972, representing 28% of total revenue[23] - Net beverage alcohol revenue surged 131.6% to $56.0 million in Q3 2024 from $24.2 million in Q3 2023[27] Gross Margin and Profit - Gross margin increased by 500 basis points to 30% in Q1[1][3] - Gross profit increased by 35% to $59,706 from $44,196[19] - Cannabis net revenue reached $61.2 million with a gross margin of 40% in Q1[3] - Cannabis adjusted gross margin improved to 40% in Q3 2024 from 35% in Q3 2023[27] Business Segments - Distribution net revenue was $68.1 million with a gross margin of 12% in Q1[3] - Wellness net revenue grew 11% to $14.8 million in Q1[3] - Cannabis business revenue declined to $61,249, accounting for 31% of total revenue[23] - Distribution business revenue slightly decreased to $68,071, making up 34% of total revenue[23] - Wellness business revenue rose to $14,752, contributing 7% of total revenue[23] - Net cannabis revenue for Q3 2024 was $61.2 million, a decrease of 12.9% compared to $70.3 million in Q3 2023[25] - Canadian adult-use cannabis revenue declined by 19.6% to $57.2 million in Q3 2024 from $71.2 million in Q3 2023[25] - International cannabis revenue decreased by 14.5% to $12.2 million in Q3 2024 from $14.3 million in Q3 2023[25] Financial Performance - Adjusted EBITDA was $9.3 million in Q1 compared to $10.7 million in the prior year quarter[3] - Operating loss widened by 6% to $(36,570) from $(34,362)[20] - Net loss decreased by 38% to $(34,652) from $(55,863)[20] - Adjusted EBITDA for Q3 2024 was $9.3 million, down 13.0% from $10.7 million in Q3 2023[27] - Net loss narrowed to $34.7 million in Q3 2024 from $55.9 million in Q3 2023, a 38% improvement[30] Cash Flow and Assets - Total assets increased to $4,261,867 from $4,221,665[18] - Net cash used in operating activities increased by 123% to $(35,307) from $(15,842)[21] - Cash and marketable securities decreased to $280.1 million as of August 31, 2024, from $466.5 million a year earlier[27] - Free cash flow was negative $42.0 million in Q3 2024, compared to negative $19.7 million in Q3 2023[33] - Working capital increased to $432.3 million as of August 31, 2024, from $292.0 million a year earlier[27] Regulatory and Market Developments - German medical cannabis flower revenue increased by 50% following legalization[1] - Tilray Alternative Beverages launched in October to fuel key U.S. markets with hemp-derived Delta-9 THC products[1] - The company anticipates improved regulatory changes in the cannabis industry following the upcoming U.S. Presidential elections[2]

Analyst's Perspective - The analyst initiated coverage of Tilray Brands Inc (NASDAQ: TLRY) with a buy rating in March, driven by Germany's new cannabis law that facilitates easier access to medical cannabis products for patients [1] - The analyst leverages experience as a former managing editor at a financial media publication focused on mid and small caps, combined with an academic background in financial markets and institutions, to identify investment opportunities in undervalued companies [1] - The analyst emphasizes thorough research and analysis of financial statements, market trends, and upcoming events that may impact specific companies or industries [1] Disclosure and Context - The analyst has no stock, option, or derivative positions in the mentioned companies and no plans to initiate such positions within the next 72 hours [2] - The article reflects the analyst's personal opinions and is not influenced by compensation or business relationships with the mentioned companies [2] - Seeking Alpha clarifies that its analysts are third-party authors, including both professional and individual investors, who may not be licensed or certified by any regulatory body [3]